Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF1144 Latest Draft

Bill / Introduced Version Filed 02/06/2025

                            1.1	A bill for an act​
1.2 relating to health occupations; modifying limitations on optometrists prescribing​
1.3 and administering drugs; amending Minnesota Statutes 2024, section 148.56,​
1.4 subdivision 1.​
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.6 Section 1. Minnesota Statutes 2024, section 148.56, subdivision 1, is amended to read:​
1.7 Subdivision 1.Optometry defined.(a) Any person shall be deemed to be practicing​
1.8optometry within the meaning of sections 148.52 to 148.62 who shall in any way:​
1.9 (1) advertise as an optometrist;​
1.10 (2) employ any means, including the use of autorefractors or other automated testing​
1.11devices, for the measurement of the powers of vision or the adaptation of lenses or prisms​
1.12for the aid thereof;​
1.13 (3) possess testing appliances for the purpose of the measurement of the powers of vision;​
1.14 (4) diagnose any disease, optical deficiency or deformity, or visual or muscular anomaly​
1.15of the visual system consisting of the human eye and its accessory or subordinate anatomical​
1.16parts;​
1.17 (5) prescribe lenses, including plano or cosmetic contact lenses, or prisms for the​
1.18correction or the relief of same;​
1.19 (6) employ or prescribe ocular exercises, orthoptics, or habilitative and rehabilitative​
1.20therapeutic vision care; or​
1​Section 1.​
25-03046 as introduced​01/30/25 REVISOR AGW/HL​
SENATE​
STATE OF MINNESOTA​
S.F. No. 1144​NINETY-FOURTH SESSION​
(SENATE AUTHORS: MAYE QUADE, Kupec, Gruenhagen, Gustafson and Utke)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​02/10/2025​
Referred to Health and Human Services​ 2.1 (7) prescribe or administer legend drugs to aid in the diagnosis, cure, mitigation,​
2.2prevention, treatment, or management of disease, deficiency, deformity, or abnormality of​
2.3the human eye and adnexa included in the curricula of accredited schools or colleges of​
2.4optometry, and as limited by Minnesota statute and adopted rules by the Board of Optometry,​
2.5or who holds oneself out as being able to do so.​
2.6 (b) In the course of treatment, nothing in this section shall allow:​
2.7 (1) legend drugs to be administered intravenously, intramuscularly, or by injection,​
2.8except for treatment of anaphylaxis or by sub-Tenon, retrobulbar, or intravitreal injection;​
2.9 (2) invasive surgery including, but not limited to, surgery using lasers;​
2.10 (3) Schedule II and III oral legend drugs and oral steroids to be administered or​
2.11prescribed; or​
2.12 (4) oral antivirals to be prescribed or administered for more than ten days; or steroids​
2.13to be administered or prescribed for more than 14 days without consultation with a physician.​
2.14 (5) oral carbonic anhydrase inhibitors to be prescribed or administered for more than​
2.15seven days.​
2​Section 1.​
25-03046 as introduced​01/30/25 REVISOR AGW/HL​